Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis — Rick van Minkelen (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis
Shared by
Frits R. Rosendaal
The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis
Letter
2005
English
Authors
+2 more
RM
Rick van Minkelen
MV
Marieke C. Visser
HV
Hans L. Vos
Abstract
1 min read
No abstract is provided for this article.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2007
Rapid genotyping of the G534E polymorphism (Marburg I) of the gene encoding the factor VII-activating protease (FSAP) by LightCycler PCR
Carmen G. Tag
,
Senait Mengsteab
,
Sandip M. Kanse
,
Ralf Weiskirchen
Letter
2005
The 46C→T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis
Rogier M. Bertina
,
S R Poort
,
Hans L. Vos
,
Frits R. Rosendaal
Journal of Thrombosis and Haemostasis
Article
2012
Circulating Factor VII Activating Protease (FSAP) Is Associated With Clinical Outcome in Acute Coronary Syndrome
Mariana S. Parahuleva
,
Hans Hölschermann
,
Daniel Zandt
,
Jörn Pons‐Kühnemann
,
Behnoush Parviz
,
Ralf Weiskirchen
,
Anne Staubitz
,
Harald Tillmanns
,
Ali Erdoğan
,
Sandip M. Kanse
Letter
2012
Plasma levels of Midkine (neurite growth‐promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis
Ton Lisman
,
Mirjam E. Meltzer
,
Suzanne C. Cannegieter
,
Frits R. Rosendaal
Journal of Thrombosis and Haemostasis
Article
2013
Prolonged clot lysis time is a risk factor for venous thrombosis
Zeki Karasu
,
Astrid van Hylckama Vlieg
,
R. Luddington
,
Caroline Baglin
,
Frits R. Rosendaal
,
Trevor Baglin
Journal of Thrombosis and Haemostasis
Discussion(0)
No comments yet. Be the first to comment.